The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Surgical Site Infection Control Global Market Report 2023, the surgical site infection control market is expected to show promising growth in the forecast period.

The surgical site infection control market has experienced notable growth, reflecting an increasing emphasis on infection prevention in surgical settings. The market is anticipated to expand from $4.51 billion in 2023 to $4.74 billion in 2024, with a compound annual growth rate (CAGR) of 5.1%.

Key Drivers of Market Growth

• Enhanced Awareness and Protocols: Greater emphasis on infection prevention protocols and integration of infection control outcomes into healthcare systems have driven market growth.
• Concerns Over Antibiotic Resistance: Rising concerns about antibiotic resistance have heightened the need for effective infection control measures.
• Value-Based Care Models: The shift towards value-based care models encourages the adoption of effective infection control strategies.
• Regulatory Standards: Stringent implementation of regulatory standards and guidelines ensures higher compliance and effectiveness in infection control.

Market Growth Forecast

The surgical site infection control market is projected to reach $5.81 billion by 2028, growing at a CAGR of 5.2%.

View More On The Surgical Site Infection Control Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/surgical-site-infection-control-global-market-report

Factors Driving Future Growth

• Minimally Invasive Procedures: Increasing demand for minimally invasive surgical procedures necessitates advanced infection control measures.
• Aging Population: An older demographic requires more surgical procedures, increasing the demand for infection control.
• Single-Use Products: Growing preference for single-use infection control products reduces the risk of cross-contamination.
• Healthcare Infrastructure Investments: Investments in healthcare infrastructure development support market expansion.
• Patient Safety Initiatives: Enhanced patient safety initiatives drive the adoption of advanced infection control solutions.

Emerging Trends

• Advanced Sterilization Methods: Continued development of advanced sterilization technologies improves infection prevention.
• Surgical Technique Innovations: Innovations in surgical techniques contribute to better infection control.
• Rise in Outpatient Surgeries: The increasing trend towards outpatient surgeries emphasizes the need for effective infection control.
• Single-Use and Disposable Products: The use of single-use and disposable products is growing, enhancing infection prevention.
• Advanced PPE Solutions: The development of advanced personal protective equipment (PPE) solutions boosts safety and compliance.

Increasing Surgical Procedures and Infection Control Strategies

The growth in surgical procedures is a significant driver for the surgical site infection control market. Advancements in technology and the rising number of chronic diseases contribute to more frequent surgeries.

Key Statistics

• Government of British Columbia Report (May 2024): There were 365,825 surgeries completed, including 284,844 scheduled surgeries, representing an increase from previous years. The rising number of surgeries highlights the growing need for effective infection control measures.

Major Players in the Market

Several key companies are prominent in the surgical site infection control market:

• Johnson & Johnson
• Thermo Fisher Scientific Inc.
• 3M Company
• Kimberly-Clark Corporation
• Becton Dickinson and Company
• Stryker Corporation
• Owens & Minor Inc.
• Zimmer Biomet Holdings Inc.
• Terumo Corporation

Innovative Developments in Surgical Gowns

Companies are focusing on developing advanced products like surgical gowns with innovative fabrics to enhance protection and comfort.

Notable Example

• Invenio Medical Inc. (March 2022): Launched the V90 series of surgical gowns featuring advanced materials that provide improved barrier properties, breathability, and durability. This development addresses the evolving needs of modern healthcare facilities by offering high-performance and cost-effective solutions.

Mergers and Acquisitions: Expanding Market Reach

Mergers and acquisitions are shaping the landscape of the surgical site infection control market.

Example: Ansell Limited and Careplus (M) Sdn Bhd

• Ansell Limited (February 2023): Acquired a 50% shareholding in Careplus (M) Sdn Bhd for $9 million. This acquisition aligns with Ansell’s strategy to enhance control over its supply chain and production capabilities in the surgical and medical glove sector.

Market Segmentation

The surgical site infection control market is segmented as follows:

1. By Product:
   • Surgical Scrubs
   • Hair Clippers
   • Surgical Drapes
   • Surgical Irrigation
   • Skin Preparation Solution
   • Medical Nonwovens
   • Surgical Gloves
   • Manual Reprocessor Solution
   • Disinfectants
   • Other Products
2. By Type of Infection:
   • Superficial Incisional Surgical Site Infection (SSI)
   • Deep Incisional Surgical Site Infection (SSI)
   • Organ or Space Surgical Site Infection (SSI)
3. By Surgery Type:
   • Cesarean Section
   • Gastric Bypass
   • Cataract Surgery
   • Dental Restoration
   • Other Surgery Types
4. By End-User:
   • Hospitals
   • Ambulatory Surgical Centers
   • Other End Users

Regional Insights

North America

• Largest Market Share in 2023: North America led the surgical site infection control market due to its advanced healthcare infrastructure and high standards for infection prevention.

Asia-Pacific

• Emerging Markets: While specific data for Asia-Pacific is not provided, the region is expected to grow due to expanding healthcare investments and increasing surgical procedures.

Request A Sample Of The Global Surgical Site Infection Control Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=17271&type=smp